Free Trial

Charlotte's Web (CWEB) Competitors

Charlotte's Web logo
C$0.25 -0.01 (-3.85%)
As of 10/16/2025 03:53 PM Eastern

CWEB vs. RX, CRDL, MDP, TGOD, NINE, DB, WMD, HEXO, VIR, and ZOM

Should you be buying Charlotte's Web stock or one of its competitors? The main competitors of Charlotte's Web include BioSyent (RX), Cardiol Therapeutics (CRDL), Medexus Pharmaceuticals (MDP), Green Organic Dutchman (TGOD), Delta 9 Cannabis (NINE), Decibel Cannabis (DB), WeedMD (WMD), HEXO (HEXO), Viridium Pacific Group (VIR), and Zomedica Pharmaceuticals Corp. (ZOM.V) (ZOM). These companies are all part of the "drug manufacturers - specialty & generic" industry.

Charlotte's Web vs. Its Competitors

Charlotte's Web (TSE:CWEB) and BioSyent (CVE:RX) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, analyst recommendations, institutional ownership, valuation, media sentiment, risk and profitability.

BioSyent has a net margin of 20.60% compared to Charlotte's Web's net margin of -66.35%. BioSyent's return on equity of 20.01% beat Charlotte's Web's return on equity.

Company Net Margins Return on Equity Return on Assets
Charlotte's Web-66.35% -83.34% -17.25%
BioSyent 20.60%20.01%12.86%

Charlotte's Web has a beta of 2.629697, meaning that its share price is 163% more volatile than the S&P 500. Comparatively, BioSyent has a beta of 0.393036, meaning that its share price is 61% less volatile than the S&P 500.

In the previous week, Charlotte's Web and Charlotte's Web both had 1 articles in the media. Charlotte's Web's average media sentiment score of 1.27 beat BioSyent's score of 1.16 indicating that Charlotte's Web is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Charlotte's Web
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
BioSyent
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

1.4% of Charlotte's Web shares are held by institutional investors. Comparatively, 4.0% of BioSyent shares are held by institutional investors. 11.3% of Charlotte's Web shares are held by insiders. Comparatively, 33.7% of BioSyent shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

BioSyent has lower revenue, but higher earnings than Charlotte's Web. Charlotte's Web is trading at a lower price-to-earnings ratio than BioSyent, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Charlotte's WebC$50.32M0.79-C$25.55M-C$0.14-1.79
BioSyentC$39.51M3.19C$7.02MC$0.7115.77

Summary

BioSyent beats Charlotte's Web on 9 of the 12 factors compared between the two stocks.

Get Charlotte's Web News Delivered to You Automatically

Sign up to receive the latest news and ratings for CWEB and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CWEB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CWEB vs. The Competition

MetricCharlotte's WebDrug Manufacturers IndustryMedical SectorTSE Exchange
Market CapC$39.78MC$1.68BC$6.08BC$9.67B
Dividend YieldN/A2.95%5.73%6.52%
P/E Ratio-1.79113.0084.6629.67
Price / Sales0.791,588.69608.0212.25
Price / Cash8.9010.3737.8683.29
Price / Book1.2611.2112.325.78
Net Income-C$25.55MC$20.70BC$3.32BC$301.20M
7 Day Performance4.17%-0.28%2.28%1.45%
1 Month Performance78.57%3.26%9.65%5.77%
1 Year Performance47.06%9.49%72.85%39.32%

Charlotte's Web Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CWEB
Charlotte's Web
N/AC$0.25
-3.8%
N/A+42.9%C$39.78MC$50.32M-1.79164Positive News
Gap Down
RX
BioSyent
N/AC$11.16
-0.8%
N/A+3.9%C$125.67MC$39.51M15.72N/APositive News
CRDL
Cardiol Therapeutics
N/AC$1.49
-2.6%
N/A-44.3%C$124.76MN/A-3.1020
MDP
Medexus Pharmaceuticals
1.4652 of 5 stars
C$2.80
+0.4%
C$4.57
+63.1%
+7.8%C$90.32MC$105.66M140.0098
TGOD
Green Organic Dutchman
N/AN/AN/AN/AC$89.95MC$31.37M-0.6541Gap Up
High Trading Volume
NINE
Delta 9 Cannabis
N/AC$1.03
+3.0%
N/A+0.0%C$89.36MC$12.87M19.07940Gap Up
DB
Decibel Cannabis
N/AC$0.14
flat
N/A+160.0%C$77.88MC$100.50M4.5083,000
WMD
WeedMD
N/AC$0.28
-1.8%
N/A+0.0%C$67.82MC$27.53M-0.66628Gap Up
HEXO
HEXO
N/AN/AN/AN/AC$38.72MC$124.10M-0.26690
VIR
Viridium Pacific Group
N/AC$0.38
+5.6%
N/A+0.0%C$37.52MC$1.09M-2.97580Gap Up
ZOM
Zomedica Pharmaceuticals Corp. (ZOM.V)
N/AC$0.29
-6.6%
N/A+0.0%C$36.73MN/A-2.6150Gap Down

Related Companies and Tools


This page (TSE:CWEB) was last updated on 10/17/2025 by MarketBeat.com Staff
From Our Partners